Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.20.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 29,494 $ 41,920
Short-term investments 0 6,494
Prepaid expenses and other current assets 2,762 3,988
Restricted cash 55 0
Total current assets 32,311 52,402
Other assets 573 812
Deferred offering costs 277 70
Restricted cash 218 273
Property and equipment, net 326 405
Operating lease right-of-use asset (See Note 7) 3,047 3,191
Total assets 36,752 57,153
Current liabilities:    
Accounts payable 5,254 7,177
Accrued expenses 3,004 3,801
Operating lease liability, current portion (See Note 7) 47 36
Total current liabilities 8,305 11,014
Warrant liabilities 2,282 18,396
Convertible debt and derivative liabilities (See Note 6) 13,275 11,522
Operating lease liability (See Note 7) 3,332 3,326
Total liabilities 27,194 44,258
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, authorized 5,000,000 shares as of September 30, 2020 and December 31, 2019; 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019 0 0
Common stock, $0.001 par value, 100,000,000 shares authorized as of September 30, 2020 and December 31, 2019; 10,798,119 and 9,741,372 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 10 10
Additional paid-in capital 293,450 284,313
Accumulated deficit (283,902) (271,428)
Total stockholders’ equity 9,558 12,895
Total liabilities and stockholders’ equity $ 36,752 $ 57,153